Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AGLNASDAQ:PGNYNASDAQ:RDNTNASDAQ:SHC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAGLAgilon Health$2.17+3.2%$3.10$1.50▼$7.73$902.41M0.144.98 million shs4.09 million shsPGNYProgyny$21.65+0.6%$21.90$13.39▼$30.42$1.86B1.321.70 million shs927,854 shsRDNTRadNet$57.12+1.0%$55.39$45.00▼$93.65$4.29B1.43688,702 shs581,354 shsSHCSotera Health$10.94-0.1%$11.91$9.53▼$17.08$3.11B1.871.23 million shs1.50 million shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAGLAgilon Health0.00%-1.45%-12.23%-51.97%-67.83%PGNYProgyny0.00%+0.46%-1.01%-0.96%-15.86%RDNTRadNet0.00%+0.95%-5.05%+15.98%-2.07%SHCSotera Health0.00%-6.89%-14.66%-8.07%-3.53%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAGLAgilon Health3.208 of 5 stars4.14.00.00.03.10.00.6PGNYProgyny1.0459 of 5 stars1.21.00.00.02.72.51.3RDNTRadNet3.7009 of 5 stars2.82.00.04.62.72.50.0SHCSotera Health2.9551 of 5 stars3.43.00.00.00.63.31.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAGLAgilon Health 2.17Hold$4.79120.74% UpsidePGNYProgyny 2.42Hold$23.458.34% UpsideRDNTRadNet 3.50Strong Buy$69.6021.85% UpsideSHCSotera Health 2.80Moderate Buy$15.8044.42% UpsideCurrent Analyst Ratings BreakdownLatest SHC, AGL, PGNY, and RDNT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/13/2025RDNTRadNetB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy ➝ Buy$69.006/12/2025RDNTRadNetB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeBuy ➝ Strong-Buy5/13/2025AGLAgilon HealthWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$6.00 ➝ $5.005/12/2025PGNYProgynyCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$23.00 ➝ $21.005/8/2025AGLAgilon HealthBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetUnderweight ➝ Underweight$2.00 ➝ $3.005/8/2025AGLAgilon HealthThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$2.50 ➝ $5.005/5/2025SHCSotera HealthThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$14.00 ➝ $17.004/28/2025AGLAgilon HealthJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Perform ➝ Market Perform4/25/2025AGLAgilon HealthCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$3.25 ➝ $5.004/23/2025SHCSotera HealthPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$15.00 ➝ $13.004/15/2025AGLAgilon HealthCowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold(Data available from 6/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAGLAgilon Health$6.06B0.15N/AN/A$1.14 per share1.90PGNYProgyny$1.17B1.59$0.35 per share62.74$4.96 per share4.36RDNTRadNet$1.83B2.34$3.48 per share16.40$15.31 per share3.73SHCSotera Health$1.10B2.82$1.20 per share9.11$1.43 per share7.65Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAGLAgilon Health-$260.15M-$0.59N/AN/AN/A-4.04%-45.47%-12.76%8/5/2025 (Estimated)PGNYProgyny$54.34M$0.5737.9833.312.284.33%10.90%7.20%8/5/2025 (Estimated)RDNTRadNet$2.79M-$0.43N/A107.77N/A-1.73%1.41%0.48%8/6/2025 (Estimated)SHCSotera Health$44.34M$0.08136.7715.63N/A2.24%41.08%5.68%8/4/2025 (Estimated)Latest SHC, AGL, PGNY, and RDNT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025PGNYProgyny$0.45$0.17-$0.28$0.17$307.86 million$324.04 million5/6/2025Q1 2025AGLAgilon Health-$0.01$0.03+$0.04$0.03$1.50 billion$1.53 billion5/1/2025Q1 2025SHCSotera Health$0.12$0.14+$0.02-$0.05$245.56 million$254.52 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAGLAgilon HealthN/AN/AN/AN/AN/APGNYProgynyN/AN/AN/AN/AN/ARDNTRadNetN/AN/AN/AN/AN/ASHCSotera HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAGLAgilon HealthN/A1.201.20PGNYProgynyN/A2.392.39RDNTRadNet0.872.012.01SHCSotera Health5.552.462.19Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAGLAgilon HealthN/APGNYProgyny94.93%RDNTRadNet77.90%SHCSotera Health91.03%Insider OwnershipCompanyInsider OwnershipAGLAgilon Health3.57%PGNYProgyny9.40%RDNTRadNet5.60%SHCSotera Health47.55%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAGLAgilon Health1,076413.95 million399.17 millionNot OptionablePGNYProgyny31085.72 million77.66 millionOptionableRDNTRadNet11,02175.03 million70.83 millionOptionableSHCSotera Health3,000283.86 million148.88 millionOptionableSHC, AGL, PGNY, and RDNT HeadlinesRecent News About These CompaniesSotera Health (NASDAQ:SHC) Receives $15.80 Consensus Price Target from BrokeragesJune 12, 2025 | americanbankingnews.comSquarepoint Ops LLC Cuts Stock Position in Sotera Health (NASDAQ:SHC)June 9, 2025 | marketbeat.comSotera Health (NASDAQ:SHC) Given Consensus Rating of "Moderate Buy" by AnalystsJune 7, 2025 | marketbeat.comSotera Health (NASDAQ:SHC) Cut to Hold at Wall Street ZenJune 7, 2025 | marketbeat.comSotera Health (NASDAQ:SHC) Stock Holdings Lowered by Bank of America Corp DEJune 6, 2025 | marketbeat.com1 Stock Under $50 to Target This Week and 2 to Be Wary OfJune 5, 2025 | msn.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Position in Sotera Health (NASDAQ:SHC)June 5, 2025 | marketbeat.comNuveen Asset Management LLC Has $5.56 Million Stake in Sotera Health (NASDAQ:SHC)June 1, 2025 | marketbeat.comNeo Ivy Capital Management Increases Stake in Sotera Health (NASDAQ:SHC)May 26, 2025 | marketbeat.comSotera Health's SWOT analysis: stock outlook amid litigation, growth focusMay 26, 2025 | investing.com1,000,000 Shares in Sotera Health (NASDAQ:SHC) Acquired by Ananym Capital Management LPMay 24, 2025 | marketbeat.comSotera Health (NASDAQ:SHC) Shares Bought by Two Seas Capital LPMay 23, 2025 | marketbeat.comSHC Q1 Earnings Call: Sotera Health Outperforms Expectations, Highlights Resilient Service DemandMay 15, 2025 | finance.yahoo.comSpotting Winners: Sotera Health Company (NASDAQ:SHC) And Research Tools & Consumables Stocks In Q1May 9, 2025 | finance.yahoo.comThere May Be Reason For Hope In Sotera Health's (NASDAQ:SHC) Disappointing EarningsMay 9, 2025 | finance.yahoo.comGoldman Sachs Upgrades Sotera Health (SHC)May 5, 2025 | msn.comWhy Sotera Health Company (SHC) Stock Is Trading Up TodayMay 5, 2025 | finance.yahoo.comSotera Health 'Is Uniquely Insulated From Potential Tariff Policy,' Goldman Sachs SaysMay 5, 2025 | benzinga.comSotera Health: Resilient Growth and Strategic Positioning Amidst Economic ChallengesMay 5, 2025 | tipranks.comWhy Sotera Health Company’s (SHC) Stock Is Up 6.26%May 5, 2025 | aaii.comGoldman Sachs Upgrades Sotera Health (SHC) to Buy with New Price Target | SHC Stock NewsMay 5, 2025 | gurufocus.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSHC, AGL, PGNY, and RDNT Company DescriptionsAgilon Health NYSE:AGL$2.17 +0.07 (+3.24%) Closing price 06/18/2025 03:59 PM EasternExtended Trading$2.17 +0.00 (+0.09%) As of 06/18/2025 05:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.Progyny NASDAQ:PGNY$21.65 +0.12 (+0.56%) Closing price 06/18/2025 04:00 PM EasternExtended Trading$21.60 -0.05 (-0.25%) As of 06/18/2025 05:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.RadNet NASDAQ:RDNT$57.12 +0.56 (+0.99%) Closing price 06/18/2025 04:00 PM EasternExtended Trading$57.13 +0.01 (+0.02%) As of 06/18/2025 04:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.Sotera Health NASDAQ:SHC$10.94 -0.01 (-0.09%) Closing price 06/18/2025 04:00 PM EasternExtended Trading$10.94 0.00 (0.00%) As of 06/18/2025 04:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems. The company also provides microbiological and analytical chemistry testing, as well as technical assistance, regulatory consulting, and advisory services. It serves medical devices, pharmaceuticals, food safety, agricultural products, cancer treatment, and high-performance materials industries, as well as commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Robinhood Director Sells Millions, But HOOD Stock Eyes Gains Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill Chime’s Smart IPO: Half the Valuation, Double the Strength 3 Tech Stocks With High and Rising Institutional Interest Salesforce Raises Prices: 3 Reasons Its Stock Price Will Follow Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
